Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Zhejiang Hisoar Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.48 Million ≈ $2.27 Million USD) by net assets (CN¥5.11 Billion ≈ $747.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

Cash flow conversion efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhejiang Hisoar Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Zhejiang Hisoar Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang Hisoar Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Hisoar Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Zhejiang Hisoar Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
American Axle & Manufacturing NYSE:AXL	0.188x
Bell AG SW:BELL	0.170x
Jiangsu Guomao Reducer Co Ltd SHG:603915	0.015x
Turning Point Brands Inc NYSE:TPB	-0.058x
Dalata Hotel Group Plc IR:DHG	0.022x
Svitzer Group A/S CO:SVITZR	N/A
Fangda Special Steel Technology Co Ltd SHG:600507	-0.008x
Adient PLC NYSE:ADNT	0.099x

Annual Cash Flow Conversion Efficiency for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. Review free cash flow generation of Zhejiang Hisoar Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.13 Billion ≈ $750.95 Million	CN¥174.83 Million ≈ $25.58 Million	0.034x	-20.66%
2023-12-31	CN¥5.60 Billion ≈ $819.71 Million	CN¥240.54 Million ≈ $35.20 Million	0.043x	+125.81%
2022-12-31	CN¥6.10 Billion ≈ $893.34 Million	CN¥116.09 Million ≈ $16.99 Million	0.019x	+13.58%
2021-12-31	CN¥6.11 Billion ≈ $894.62 Million	CN¥102.36 Million ≈ $14.98 Million	0.017x	-81.65%
2020-12-31	CN¥5.85 Billion ≈ $856.34 Million	CN¥533.87 Million ≈ $78.12 Million	0.091x	-14.72%
2019-12-31	CN¥5.72 Billion ≈ $837.67 Million	CN¥612.40 Million ≈ $89.61 Million	0.107x	-27.14%
2018-12-31	CN¥5.39 Billion ≈ $788.81 Million	CN¥791.45 Million ≈ $115.81 Million	0.147x	+635.28%
2017-12-31	CN¥5.14 Billion ≈ $752.44 Million	CN¥102.68 Million ≈ $15.02 Million	0.020x	-84.87%
2016-12-31	CN¥4.77 Billion ≈ $698.05 Million	CN¥629.42 Million ≈ $92.10 Million	0.132x	+2.00%
2015-12-31	CN¥3.57 Billion ≈ $522.81 Million	CN¥462.16 Million ≈ $67.63 Million	0.129x	+114.65%
2014-12-31	CN¥3.18 Billion ≈ $465.15 Million	CN¥191.56 Million ≈ $28.03 Million	0.060x	-37.33%
2013-12-31	CN¥632.80 Million ≈ $92.60 Million	CN¥60.85 Million ≈ $8.90 Million	0.096x	-60.73%
2012-12-31	CN¥738.05 Million ≈ $108.00 Million	CN¥180.73 Million ≈ $26.45 Million	0.245x	+94.84%
2011-12-31	CN¥736.96 Million ≈ $107.84 Million	CN¥92.62 Million ≈ $13.55 Million	0.126x	-55.67%
2010-12-31	CN¥638.04 Million ≈ $93.36 Million	CN¥180.88 Million ≈ $26.47 Million	0.283x	+61.88%
2009-12-31	CN¥561.79 Million ≈ $82.21 Million	CN¥98.38 Million ≈ $14.40 Million	0.175x	+213.25%
2008-12-31	CN¥547.50 Million ≈ $80.12 Million	CN¥30.61 Million ≈ $4.48 Million	0.056x	-41.18%
2007-12-31	CN¥538.06 Million ≈ $78.73 Million	CN¥51.14 Million ≈ $7.48 Million	0.095x	-20.24%
2006-12-31	CN¥519.27 Million ≈ $75.99 Million	CN¥61.88 Million ≈ $9.06 Million	0.119x	-39.55%
2005-12-31	CN¥182.96 Million ≈ $26.77 Million	CN¥36.07 Million ≈ $5.28 Million	0.197x	-38.55%
2004-12-31	CN¥132.03 Million ≈ $19.32 Million	CN¥42.36 Million ≈ $6.20 Million	0.321x	+600.11%
2003-12-31	CN¥85.03 Million ≈ $12.44 Million	CN¥-5.45 Million ≈ $-798.23K	-0.064x	--

About Zhejiang Hisoar Pharmaceutical Co Ltd

SHE:002099 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.36 Billion

CN¥9.31 Billion CNY

Market Cap Rank

#7388 Global

#1559 in China

Share Price

CN¥5.75

Change (1 day)

+1.77%

52-Week Range

CN¥4.98 - CN¥8.83

All Time High

CN¥11.31